"Jjp Ventures" Sp. z o.o. (Poland)

JJP Ventures Sp. z o.o. is a Warsaw-based limited liability company operating in the area of management of companies and enterprises, formally classified under head office activities. The company is controlled by members of the Starak family, which is actively involved in life sciences investments in Poland. JJP Ventures functions as a corporate and holding platform for these investments, including JJP Biologics, an innovative Polish biotechnology company focused on the development of novel biological therapeutics in immunology and oncology based on companion diagnostics and personalized medicine approaches. Through its role as a holding and head-office entity, JJP Ventures is involved in strategic management, capital allocation and oversight of the group's biotechnology projects, supporting the progression of a pipeline of monoclonal antibody programs such as anti-CD89 (JJP-1212) for IgA-mediated autoimmune and fibrotic diseases and anti-CD270 (JJP-1008) for solid tumors and hematologic malignancies. Geographically, the company is anchored in Poland but its portfolio activities have a European and global dimension through scientific collaborations, clinical development and participation in international industry events. Strategically, JJP Ventures focuses on building long-term value in the high-growth biotechnology segment, combining scientific expertise, private capital backing and a personalized medicine orientation.